| |
| Device | ENROUTE TRANSCAROTID STENT SYSTEM |
| Generic Name | Stent, carotid |
| Applicant | Boston Scientific Corporation 300 Boston Scientific Way Marborough, MA 01752 |
| PMA Number | P140026 |
| Date Received | 11/17/2014 |
| Decision Date | 05/18/2015 |
| Product Code |
NIM |
| Docket Number | 15M-1956 |
| Notice Date | 06/02/2015 |
| Advisory Committee |
Cardiovascular |
| Clinical Trials | NCT01685567
|
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement APPROVAL FOR THE ENROUTE TRANSCAROTID STENT SYSTEM. THIS DEVICE IS INDICATED FOR USE IN CONJUNCTION WITH THE ENROUTE TRANSCAROTID NEUROPROTECTION SYSTEM (NPS) FOR THE TREATMENT OF PATIENTS AT HIGH RISKFOR ADVERSE EVENTS FROM CAROTID ENDARTERECTOMY WHO REQUIRE CAROTID REVASCULARIZATION AND MEET THE CRITERIA OUTLINED BELOW.1) PATIENTS WITH NEUROLOGICAL SYMPTOMS AND >= 50% STENOSIS OF THE COMMON OR INTERNAL CAROTID ARTERY BY ULTRASOUND OR ANGIOGRAM OR PATIENTS WITHOUT NEUROLOGICAL SYMPTOMS AND >=80% STENOSIS OF THE COMMON OR INTERNAL CAROTID ARTERY BY ULTRASOUND OR ANGIOGRAM; 2) PATIENTS MUST HAVE A VESSEL DIAMETER OF 4-9MM AT THE TARGET LESION; AND 3) CAROTID BIFURCATION IS LOCATED AT MINIMUM 5 CM ABOVE THE CLAVICLE TO ALLOW FOR PLACEMENT OF THE ENROUTE TRANSCAROTID NPS. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling
|
| Post-Approval Study | Show Report Schedule and Study Progress |
| Supplements: |
S005 S006 S001 S002 S004 S003 S008 S014 S019 S020 S024 S027 S030 S033 S009 S010 S015 S013 S012 S011 S021 S023 S025 S026 S016 S017 S018 S031 S029 S032 S028 |